68.20TRY+0.15%Mkt Cap: 13.35B TRYP/E: —Last update: 2026-05-14
Deva Holding A.S. manufactures, markets, and sells pharmaceutical products in Turkey. The company offers antineoplastic and immunomodulating agents; dermatological products; systemic hormanal preparations; anti-infective…
Industry Peers
Drug Manufacturers - Specialty & Generic153.14BSEKP/E 167.7
58.14BTRYP/E 27.8
51.02BEURP/E 20.1
13.68BEURP/E 31.2
13.10BSEKP/E 39.5
3.09BTRY—
3.02BEURP/E 25.0
2.79BEURP/E 24.1
loading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
P/B0.51
P/S0.68
EV/EBITDA10.08
EV/Revenue0.79
EPS (TTM)-4.60
EPS (Forward)—
Cash Flow & Leverage
FCF Yield-26.59%
FCF Margin-18.04%
Operating CF5.28B TRY
CapEx (TTM)2.36B TRY
Net Debt/EBITDA1.45
Net Debt2.24B TRY
Technical
SMA 5064.47 (+5.8%)
SMA 20066.17 (+3.1%)
Beta—
S&P 52W Chg24.23%
Avg Vol (30d)756.45K
Avg Vol (10d)1.12M
Technical Indicators
RSI (14)54.1
MACD1.1047
MACD Signal1.0229
MACD Hist.+0.0818
BB Upper71.31 TRY
BB Middle67.66 TRY
BB Lower64.02 TRY
BB Width10.77%
ATR (14)2.304 TRY
Vol Ratio (20d)0.42x
52W Range
51.0056% of range81.75
52W High81.75 TRY
52W Low51.00 TRY
Profitability
Gross Margin32.76%
EBITDA Margin7.86%
Profit Margin-4.19%
Oper. Margin5.88%
ROE-3.07%
ROA-2.14%
Revenue Growth33.20%
Earnings Growth—
Balance Sheet
Debt/Equity0.23
Current Ratio2.00
Quick Ratio1.28
Book Value/Sh131.59 TRY
Cash/Share22.16 TRY
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 TRY
Div. Yield—
5Y Avg Yield0.35%
Payout Ratio0.00%
Ex-Div DateJun 25, 2024
Pay Date—
Splits
Last Split1:1000
Split DateJan 3, 2005
Ownership
Shares Out.200.02M
Float35.60M
Insiders82.20%
Institutions0.33%
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Company
Market Cap13.35B TRY
Enterprise Value15.59B TRY
Revenue (TTM)19.68B TRY
Gross Profit6.30B TRY
Net Income (TTM)-806.99M TRY
Revenue/Share96.22 TRY
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees3.0K
Last Price68.20 TRY
CountryTR
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—